• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向受体、转运体及吸收部位以改善口服药物递送

Targeting receptors, transporters and site of absorption to improve oral drug delivery.

作者信息

Hamman J H, Demana P H, Olivier E I

机构信息

School of Pharmacy, Tshwane University of Technology, Private Bag X680, Pretoria, 0001, South Africa.

出版信息

Drug Target Insights. 2007;2:71-81. Epub 2007 Mar 6.

PMID:21901064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3155234/
Abstract

Although the oral route of drug administration is the most acceptable way of self-medication with a high degree of patient compliance, the intestinal absorption of many drugs is severely hampered by different biological barriers. These barriers comprise of biochemical and physical components. The biochemical barrier includes enzymatic degradation in the gastrointestinal lumen, brush border and in the cytoplasm of the epithelial cells as well as efflux transporters that pump drug molecules from inside the epithelial cell back to the gastrointestinal lumen. The physical barrier consists of the epithelial cell membranes, tight junctions and mucus layer. Different strategies have been applied to improve the absorption of drugs after oral administration, which range from chemical modification of drug molecules and formulation technologies to the targeting of receptors, transporters and specialized cells such as the gut-associated lymphoid tissues. This review focuses specifically on the targeting of receptor-mediated endocytosis, transporters and the absorption-site as methods of optimizing intestinal drug absorption. Intestinal epithelial cells express several nutrient transporters that can be targeted by modifying the drug molecule in such a way that it is recognized as a substrate. Receptor-mediated endocytosis is a transport mechanism that can be targeted for instance by linking a receptor substrate to the drug molecule of interest. Many formulation strategies exist for enhancing drug absorption of which one is to deliver drugs at a specific site in the gastrointestinal tract where optimum drug absorption takes place.

摘要

尽管口服给药途径是自我给药最易接受的方式,患者依从性高,但许多药物的肠道吸收受到不同生物屏障的严重阻碍。这些屏障由生化和物理成分组成。生化屏障包括胃肠道管腔、刷状缘以及上皮细胞胞质内的酶促降解,还有将药物分子从上皮细胞内泵回胃肠道管腔的外排转运体。物理屏障由上皮细胞膜、紧密连接和黏液层组成。为提高口服给药后药物的吸收,人们采用了不同策略,从药物分子的化学修饰、制剂技术到靶向受体、转运体以及诸如肠道相关淋巴组织等特殊细胞。本综述特别关注靶向受体介导的内吞作用、转运体和吸收部位,将其作为优化肠道药物吸收的方法。肠上皮细胞表达多种营养转运体,通过以某种方式修饰药物分子使其被识别为底物,从而靶向这些转运体。受体介导的内吞作用是一种转运机制,例如通过将受体底物与目标药物分子连接来靶向该机制。存在许多增强药物吸收的制剂策略,其中之一是在胃肠道的特定部位给药,该部位药物吸收最佳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0333/3155234/6b75eb3dfa32/dti-2-2007-071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0333/3155234/6b75eb3dfa32/dti-2-2007-071f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0333/3155234/6b75eb3dfa32/dti-2-2007-071f1.jpg

相似文献

1
Targeting receptors, transporters and site of absorption to improve oral drug delivery.靶向受体、转运体及吸收部位以改善口服药物递送
Drug Target Insights. 2007;2:71-81. Epub 2007 Mar 6.
2
Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.肠道吸收研究:改善口服药物递送中的挑战与吸收增强策略
Pharmaceuticals (Basel). 2022 Aug 8;15(8):975. doi: 10.3390/ph15080975.
3
Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery.口服给药中逆转肠道药物外排的策略与机制
Pharmaceutics. 2022 May 26;14(6):1131. doi: 10.3390/pharmaceutics14061131.
4
Targeting intestinal transporters for optimizing oral drug absorption.针对肠道转运体优化口服药物吸收。
Curr Drug Metab. 2010 Nov;11(9):730-42. doi: 10.2174/138920010794328850.
5
The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications.人肠上皮细胞系Caco-2;药理学和药代动力学应用。
Cell Biol Toxicol. 1995 Aug;11(3-4):187-94. doi: 10.1007/BF00756522.
6
[Molecular characterization of intestinal absorption of drugs by carrier-mediated transport mechanisms].
Yakugaku Zasshi. 1997 Jul;117(7):415-34. doi: 10.1248/yakushi1947.117.7_415.
7
Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.提高极性神经氨酸酶抑制剂的口服吸收:前药转运体方法在奥司他韦类似物中的应用。
Mol Pharm. 2013 Feb 4;10(2):512-22. doi: 10.1021/mp300564v. Epub 2013 Jan 4.
8
Oral delivery of peptide drugs: barriers and developments.肽类药物的口服给药:障碍与进展
BioDrugs. 2005;19(3):165-77. doi: 10.2165/00063030-200519030-00003.
9
[Physiology of intestinal absorption].[肠道吸收生理学]
Rev Prat. 2001 May 15;51(9):945-52.
10
A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans.关于外排转运体在13种常用底物药物人体胃肠道吸收中作用的全面阐述。
Int J Clin Pharmacol Ther. 2001 Mar;39(3):93-101. doi: 10.5414/cpp39093.

引用本文的文献

1
Challenges and Opportunities in the Oral Delivery of Recombinant Biologics.重组生物制品口服给药的挑战与机遇
Pharmaceutics. 2023 May 5;15(5):1415. doi: 10.3390/pharmaceutics15051415.
2
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.蛋白质和肽的口服递送:挑战、现状与未来展望。
Acta Pharm Sin B. 2021 Aug;11(8):2416-2448. doi: 10.1016/j.apsb.2021.04.001. Epub 2021 Apr 29.
3
Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.

本文引用的文献

1
Is the oral route possible for peptide and protein drug delivery?肽和蛋白质药物递送采用口服途径可行吗?
Drug Discov Today. 2006 Oct;11(19-20):905-10. doi: 10.1016/j.drudis.2006.08.005. Epub 2006 Sep 7.
2
Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET.使用基于中链脂肪酸的固体剂型促进人体药物吸收:GIPET。
Expert Opin Drug Deliv. 2006 Sep;3(5):685-92. doi: 10.1517/17425247.3.5.685.
3
Time-controlled oral delivery systems for colon targeting.用于结肠靶向的定时口服给药系统。
用于胃肠道区域靶向的口服药物递送进展——生理、病理生理和药学因素的影响
Front Pharmacol. 2020 Apr 28;11:524. doi: 10.3389/fphar.2020.00524. eCollection 2020.
4
Ticagrelor-induced life-threatening bleeding via the cyclosporine-mediated drug interaction: A case report.替格瑞洛通过环孢素介导的药物相互作用导致危及生命的出血:一例报告。
Medicine (Baltimore). 2017 Sep;96(37):e8065. doi: 10.1097/MD.0000000000008065.
5
Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.壳聚糖-海藻酸盐微胶囊为靶向细胞间黏附分子-1的纳米载体提供胃保护和肠道释放功能,实现体内胃肠道靶向。
Adv Funct Mater. 2016 May 24;26(20):3382-3393. doi: 10.1002/adfm.201600084. Epub 2016 Apr 23.
6
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.表面化学对纳米颗粒与胃肠道黏液相互作用以及小鼠口服和直肠给药后在胃肠道中分布的影响。
J Control Release. 2015 Jan 10;197:48-57. doi: 10.1016/j.jconrel.2014.10.026. Epub 2014 Nov 4.
7
Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters.了解转运蛋白的特异性以及转运蛋白中类似通道的门控结构域的离散出现。
Front Pharmacol. 2014 Sep 12;5:207. doi: 10.3389/fphar.2014.00207. eCollection 2014.
8
Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity.载胰岛素生物素修饰脂质体增强降血糖作用:制剂变量、细胞内转运和细胞毒性的影响。
Nanoscale Res Lett. 2014 Apr 16;9(1):185. doi: 10.1186/1556-276X-9-185. eCollection 2014.
9
Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?胰高血糖素样肽-1及其类似物的口服给药:糖尿病控制的替代方案?
J Diabetes Sci Technol. 2012 Nov 1;6(6):1486-97. doi: 10.1177/193229681200600630.
10
Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1.靶向细胞间黏附分子-1诱导的新型细胞旁路转运纳米载体穿越胃肠道上皮细胞的研究
J Control Release. 2012 Oct 10;163(1):25-33. doi: 10.1016/j.jconrel.2012.06.007. Epub 2012 Jun 12.
Expert Opin Drug Deliv. 2006 Sep;3(5):583-97. doi: 10.1517/17425247.3.5.583.
4
Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.口服给药后药物的吸收部位:胃肠道各段药物膜通透性和管腔浓度的评估
Eur J Pharm Sci. 2006 Nov;29(3-4):240-50. doi: 10.1016/j.ejps.2006.06.004. Epub 2006 Jun 27.
5
Chemical modification and formulation approaches to elevated drug transport across cell membranes.提高药物跨细胞膜转运的化学修饰和制剂方法。
Expert Opin Drug Deliv. 2006 Jul;3(4):511-27. doi: 10.1517/17425247.3.4.511.
6
Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery.P-糖蛋白在限制口服药物吸收中的功能作用:优化药物递送。
Curr Opin Chem Biol. 2006 Aug;10(4):367-73. doi: 10.1016/j.cbpa.2006.06.015. Epub 2006 Jun 30.
7
Gastroretentive drug delivery systems.胃滞留型药物递送系统
Expert Opin Drug Deliv. 2006 Mar;3(2):217-33. doi: 10.1517/17425247.3.2.217.
8
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.胃滞留剂型:概述及幽门螺杆菌的特殊情况
J Control Release. 2006 Mar 10;111(1-2):1-18. doi: 10.1016/j.jconrel.2005.10.031. Epub 2006 Jan 5.
9
The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).泵的作用机制:P-糖蛋白(ABCB1)的作用机制
Eur J Pharm Sci. 2006 Apr;27(5):392-400. doi: 10.1016/j.ejps.2005.10.010. Epub 2005 Dec 13.
10
Role of efflux pumps and metabolising enzymes in drug delivery.外排泵和代谢酶在药物递送中的作用。
Expert Opin Drug Deliv. 2005 Jul;2(4):683-705. doi: 10.1517/17425247.2.4.683.